| | (Reuters) - Law firm leaders at Patton Boggs in Washington, D.C., were tallying votes on Tuesday on a proposed merger with Squire Sanders, a deal that is expected to be approved and that would provide financial relief to struggling Patton Boggs. | |  | | | (Reuters) - American Realty Capital Properties Inc said it planned to sell nearly all of its shopping centers to Blackstone Group LP for $1.98 billion in cash. | | | | | | NEW YORK (Reuters) - Goldman Sachs has begun a formal process to sell the metals warehousing business it purchased four years ago, a spokesman said on Tuesday, disclosing the first definitive effort to shed the operation amid regulatory and political pressure. | | | | | | AMSTERDAM (Reuters) - Russia's Novatek is in talks with Asia-based companies on the sale of a stake in the Yamal LNG project, Mark Gyetvay, its chief financial officer, said on Wednesday. | | | | | | PARIS (Reuters) - France's controversial decree widening its control over takeovers in strategic industries is meant to help discussions over alliances and is not there to block deals, Economy Minister Arnaud Montebourg told lawmakers on Tuesday. | | | | | | LONDON (Reuters) - Some leading AstraZeneca Plc shareholders were at odds over whether the British drugmaker made the right decision in rejecting Pfizer Inc's final $118 billion bid to buy the company. | | | | | | NEW YORK (Reuters) - Clayton, Dubilier & Rice LLC is in advanced talks to acquire wound care company Healogics Inc from private equity peer Metalmark Capital Holdings LLC for around $1 billion, according to people familiar with the matter. | | | | | | MILAN (Reuters) - The biggest shareholder in Banca Carige sold an 11 percent stake in the Italian bank, less than it had planned, at a deep discount on Wednesday, sending shares in the mid-sized lender down by as much as 18 percent. | | | | | NEW YORK (Reuters) - Private equity firm Warburg Pincus LLC is close to a deal to acquire Wencor Group LLC, a manufacturer of commercial aircraft parts, for between $800 million and $900 million, people familiar with the matter said on Tuesday. | | | | | | LAVAL, QUEBEC (Reuters) - Canada's Valeant Pharmaceuticals International said on Tuesday it will not make an all-cash bid for drugmaker Allergan Inc as many had expected last week when the company said it would improve its cash and stock offer for the Botox maker. | | | |  |  | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | |  | |  | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment